- Home
- CAN vs HQL Comparison
CAN vs HQL Comparison
Compare CAN & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAN
- HQL
- Stock Information
- Founded
- CAN 2013
- HQL 1992
- Country
- CAN Singapore
- HQL United States
- Employees
- CAN N/A
- HQL N/A
- Industry
- CAN Semiconductors
- HQL Investment Managers
- Sector
- CAN Technology
- HQL Finance
- Exchange
- CAN Nasdaq
- HQL Nasdaq
- Market Cap
- CAN 384.3M
- HQL 369.6M
- IPO Year
- CAN 2019
- HQL N/A
- Fundamental
- Price
- CAN $0.61
- HQL $12.54
- Analyst Decision
- CAN Strong Buy
- HQL
- Analyst Count
- CAN 6
- HQL 0
- Target Price
- CAN $2.67
- HQL N/A
- AVG Volume (30 Days)
- CAN 36.3M
- HQL 120.9K
- Earning Date
- CAN 08-14-2025
- HQL 01-01-0001
- Dividend Yield
- CAN N/A
- HQL 11.56%
- EPS Growth
- CAN N/A
- HQL N/A
- EPS
- CAN N/A
- HQL 0.79
- Revenue
- CAN $317,009,000.00
- HQL N/A
- Revenue This Year
- CAN $160.28
- HQL N/A
- Revenue Next Year
- CAN $35.68
- HQL N/A
- P/E Ratio
- CAN N/A
- HQL $17.08
- Revenue Growth
- CAN 65.68
- HQL N/A
- 52 Week Low
- CAN $0.53
- HQL $11.34
- 52 Week High
- CAN $3.27
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- CAN 42.54
- HQL 48.60
- Support Level
- CAN $0.67
- HQL $12.49
- Resistance Level
- CAN $0.72
- HQL $13.00
- Average True Range (ATR)
- CAN 0.05
- HQL 0.21
- MACD
- CAN 0.00
- HQL -0.02
- Stochastic Oscillator
- CAN 21.64
- HQL 39.69
About CAN Canaan Inc.
Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment as well as the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.